Company signals
Harvey
2 signals in the current window, with MitchelLake's leadership read on each.
Last updated
Market context: MitchelLake's Talent Market Index sits at 112.9 (Hot), up 11.4 on the prior month; Americas hiring signal is running rising (+2.5pts).
Harvey: 1 signal in the last 90 days; 0.1% of MitchelLake's Americas signal flow; 2 tracked across 79 days.
Signals at Harvey
Product Launch
AmericasHarvey's AI token consumption increased 12x in five months (1 trillion tokens in January to 12-13 trillion in May 2026), indicating rapid product adoption and scaling. CEO publicly discussed the emerging challenge of AI cost optimization and ROI justification as usage scales dramatically across law firms and corporate legal teams.
Leadership read: Product momentum tends to widen the sector product and commercial leadership bench strength.
curated · 2026-06-19 · context →
Capital Raising
AmericasHarvey raised $200 million at an $11 billion valuation, with backing from top-tier VCs (Sequoia, a16z, Kleiner Perkins, Coatue). Company has $200M+ annualized revenue and is in intense competition with Legora for legal AI market dominance.
Leadership read: Fresh capital usually broadens the sector leadership bench strength — scale, go-to-market and operational depth — rather than any single appointment.
curated · 2026-04-01 · context →
MitchelLake in this thematic
More signals across Americas
Capital Raising · Americas
Forage →Forage raised $40 million Series B funding from Mouro Capital at $225 million valuation for SNAP EBT payment processor
Capital Raising · Americas
Nuveen →Nuveen Energy Infrastructure Credit closed $546M preferred equity investment in SunZia, the largest renewable energy infrastructure project in U.S. history
Capital Raising · Americas
BridgeBio →BridgeBio secured funding to support drug launch; United Airlines made an investment into the cell therapy space
Capital Raising · Americas
Joby Aviation →Joby Aviation expects to secure Toyota's second $250 million investment before year-end 2026, indicating continued strategic funding from a major automotive OEM partner.
Capital Raising · Americas
Beeline →Beeline, a Bain Capital-backed biotech company, upsized its Series A round and has now raised over $426 million to advance a portfolio of Bristol Myers drugs for immune-related indications.
Capital Raising · Americas
Odyssey →Odyssey (Palo Alto, CA) raised $310M Series B led by Natural Capital with Amazon and AMD Ventures, valuing the company at $1.45B. Focus: world models for physical AI and real-world environment simulation.
Intelligence powered by Autonodal ↗